OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Gut Microbiota in Tumor Immunotherapy
Miao Wu, Jiawei Bai, Chengtai Ma, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Probiotics, prebiotics, and postbiotics in health and disease
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 127

Microbiome as a biomarker and therapeutic target in pancreatic cancer
Ghazaleh Pourali, Danial Kazemi, Amir Shayan Chadeganipour, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 22

Microbial Therapy and Breast Cancer Management: Exploring Mechanisms, Clinical Efficacy, and Integration within the One Health Approach
Charalampos Filippou, Sophia Themistocleous, Giorgos Marangos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1110-1110
Open Access | Times Cited: 18

Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yunwei Yang, Yaping An, Yue Dong, et al.
EBioMedicine (2024) Vol. 100, pp. 104967-104967
Open Access | Times Cited: 18

The involvement of Th1 cell differentiation in the anti-tumor effect of purified polysaccharide from Sanghuangporus vaninii in colorectal cancer via multi-omics analysis
Yidi Qu, Hongxin Yang, Siyu Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 237, pp. 123927-123927
Closed Access | Times Cited: 23

Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
M. Vitorino, Susana Baptista de Almeida, Diogo Alpuim Costa, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 29

Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism
Yiqing Gu, Qi Zheng, Guifang Fan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11042-11042
Open Access | Times Cited: 25

Interaction of Gut Microbiota with Endocrine Homeostasis and Thyroid Cancer
Qi Liu, Wei Sun, Hao Zhang
Cancers (2022) Vol. 14, Iss. 11, pp. 2656-2656
Open Access | Times Cited: 23

Engineered inulin-based hybrid biomaterials for augmented immunomodulatory responses
Ashok Kumar Jangid, Kyung Mu Noh, Sung Jun Kim, et al.
Carbohydrate Polymers (2024) Vol. 340, pp. 122311-122311
Closed Access | Times Cited: 5

Exopolysaccharides: Exploring their role as postbiotics
S. Vijayalakshmi, Ramachandran Chelliah, Kaliyan Barathikannan, et al.
Elsevier eBooks (2025), pp. 181-206
Closed Access

Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment
Wei-Qiang Huang, Tao Jiang, Jiaxuan He, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access

Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy
Pei Zhou, Yawen Hu, Xiaoyan Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19

High-salt diet decreases FOLFOX efficacy via gut bacterial tryptophan metabolism in colorectal cancer
Yufei Deng, Xiaoying Hou, Fang Qian, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access

Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming Improvements
Aurore Dougé, Nathan El-Ghazzi, Richard Lemal, et al.
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 3, pp. 272-284
Closed Access | Times Cited: 7

Revolutionizing disease treatment through bioengineered probiotics and glucagon‐like peptide 1 (GLP‐1) based strategies: A path towards effective cures
Smriti Jain, Adarsh Kumar Shukla, DEEPIKA DEEPIKA, et al.
Food Bioengineering (2024) Vol. 3, Iss. 3, pp. 280-300
Open Access | Times Cited: 2

Probiotics and live biotherapeutic products aiming at cancer mitigation and patient recover
Zelinda Schemczssen-Graeff, Marcos Pileggi
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 12

Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
Liuyun Zhang, Yunhui Xiang, Yanying Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12

Interactions of Nanomaterials with Gut Microbiota and Their Applications in Cancer Therapy
Xiaohui Li, Huan Wei, Jiachen Qi, et al.
Sensors (2023) Vol. 23, Iss. 9, pp. 4428-4428
Open Access | Times Cited: 5

Advances in the role of gut microbiota in the regulation of the tumor microenvironment (Review)
Tian Xinyuan, Lei Yu, Shi Jianping, et al.
Oncology Reports (2023) Vol. 50, Iss. 4
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top